Remi Barbier

REMI BARBIER, Pain Therapeutics, Inc.s Founder, serves as President,
CEO and Chairman of the company. Prior to PTI, Mr. Barbier helped in the
growth or founding of: Exelixis Inc., a functional genomics company;
ArQule, a chemistry company; and EnzyMed (now owned by Albany Molecular
Research), a chemistry company. Mr. Barbier served as Chief Operating
Officer of Exelixis. Prior to that, he was Vice President of Corporate
Development and Clinical Project Manager of Xoma Corporation, a
biotechnology company. Mr. Barbier received his BA from Oberlin College
and his MBA from the University of Chicago.